Versitech Limited
63 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 2 name spellings.
Recorded as renamed to University of Hong Kong Versitech Limited (2026)
24
Ending by 2030
Nov 2026
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 4 fees due Jan 2 to 30, 2027 · next Jan 2
- 2 fees due Feb 4 to 13, 2027 · next Feb 4
- 3 fees due Mar 3 to 24, 2027 · next Mar 3
- 2 fees due Apr 17 to 20, 2027 · next Apr 17
- 2 fees due May 3 to 28, 2027 · next May 3
- 3 fees due Jun 8 to 26, 2027 · next Jun 8
- 2 fees due Jul 9 to 19, 2027 · next Jul 9
- 2 fees due Aug 4 to 16, 2027 · next Aug 4
- 2 fees due Sep 17 to 30, 2027 · next Sep 17
- 1 fee due Oct 5, 2027The maintenance fee for Platinum(II) Complexes for OLED Applications (US 9,306,178) comes due Oct 5, 2027. Unpaid by Apr 5, 2028, it lapses early.
- 1 fee due Nov 12, 2027The maintenance fee for Antibacterial Cyclic Lipopeptides (US 10,647,746) comes due Nov 12, 2027. Unpaid by May 12, 2028, it lapses early.
Recent changes
- 2 of the patents on this record were granted since Aug 16, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,839,694 | Compositions and Methods for Promoting Hemostasis and Other Physiological Activities In force · Medium confidence | In force | Medium confidence | |
| US 7,803,234 | Surface Treated Shape Memory Materials and Methods for Making Same In force · High confidence | In force | High confidence | |
| US 9,511,113 | Compositions and Methods for Affecting Movement of Contaminants, Bodily Fluids or Other Entities, And/Or Affecting Other Physiological Conditions In force · High confidence | In force | High confidence | |
| US 10,137,166 | Compositions and Methods for Affecting Movement of Contaminants, Bodily Fluids or Other Entities, And/Or Affecting Other Physiological Conditions In force · Medium confidence | In force | Medium confidence | |
| US 9,464,271 | Cell-Matrix Microspheres, Methods for Preparation and Applications In force · High confidence | In force | High confidence | |
| US 8,329,400 | Methods for Nucleic Acid Mapping and Identification of Fine-Structural-Variations in Nucleic Acids In force · Low confidence | In force | Low confidence | |
| US 8,030,097 | LIPOCALIN-2 as a Prognostic and Diagnostic Marker for Heart and Stroke Risks In force · High confidence | In force | High confidence | |
| US 7,816,400 | Use of Acacetin and Related Compounds as Potassium Channel Inhibitors In force · High confidence | In force | High confidence | |
| US 8,461,198 | Use of acacetin and related compounds as potassium channel inhibitors In force · From the USPTO record | In force | From the USPTO record | |
| US 9,096,831 | Methods to Enhance Cell Migration and Engraftment In force · High confidence | In force | High confidence |
Also on record, not counted in the 111: 63 patents in force now held by others · 18 lapsed for an unpaid fee · 46 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
43 pending · 10 abandoned · 14 no status recorded